Chairman and CEO Wu Yusheng increased his holdings of Tongyuankang Pharmaceutical-B (02410) by 400,000 shares at a price of approximately HK$2.82 per share

The Zhitong Finance App learned that the latest data from the Hong Kong Stock Exchange shows that on September 14, Chairman and CEO Wu Yusheng increased his holdings of Tongyuankang Pharmaceutical-B (02410) by 400,000 shares, at a price of HK$2.8157 each, for a total amount of about HK$1.1263 million. After the increase in holdings, the latest number of shares held was approximately 125 million shares, and the latest shareholding ratio was 32.8%.